BioSpace News Archive

Children’s Hospital of Philadelphia is proud to be recognized by the 2019 Disability Equality Index as a leader in “Best Places to Work for Disability Inclusion.” The DEI is the nation’s most comprehensive annual benchmarking tool used to survey employers’ disability policies, practices and initiatives.

The Multiple Sclerosis Association of America (MSAA) is proud to announce a new Chief Medical Officer (CMO) for the organization

As Medical Director for one of the largest women’s hospitals in the country, Steven Spedale, MD, FAAP, a well-known neonatologist, grew frustrated with the limits of available electronic medical records (EMR) systems on the market

To build on the health system’s recent brand launch on May 1, Emanate Health, formerly Citrus Valley Health Partners, today is hitting the digital airwaves and coming to the iHeart Radio App in communities throughout the San Gabriel Valley to help reach the one million residents it serves.

The style of tackling used in rugby may be associated with a lower force of impact than the style used in football, according to a preliminary study of college athletes released that will be presented at the American Academy of Neurology Sports Concussion Conference in Indianapolis July 26–28, 2019.

The Arizona Technology Council, in partnership with the Arizona Commerce Authority (ACA), will honor technology leaders and innovators from across the state at the 16th annual Governor’s Celebration of Innovation Awards (GCOI) on October 24, 2019, at the Phoenix Convention Center.

NorthShore University HealthSystem has opened the only orthopaedic specialty hospital in Illinois with a focus on providing advanced orthopaedic and spine care for the growing number of Americans in need of expert bone, joint, and spine services.

Epilepsy Foundation announced today it has elected three new board members who bring their professional expertise and personal epilepsy journeys to the Foundation’s already strong Board of Directors.

Bioasis Technologies Inc. announced that it has granted stock options to acquire a total of 1,576,240 common shares at a price of $0.27 per share to directors and officers of the company, including 510,000 options granted to Mario Saltarelli, who joined the board as a new director in May 2019 and 391,240 options granted to Deborah Rathjen, President & Chief Executive Officer, in lieu of cash compensation.

Three Canadian leaders from the worlds of media, law and Hi-tech have joined the board of Kidney Cancer Canada | Cancer du rein Canada.